+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
ID06975995

Study of Oral Postbiotics to Improve Quality of Life and Nutrition in Elderly Patients on Hemodialysis

Led by Peking University First Hospital · Updated on 2025-05-16

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research investigates the impact of giving postbiotics to elderly patients who are undergoing hemodialysis, focusing on their quality of life and nutritional health. The study targets patients aged 65 and older who have been receiving hemodialysis for more than six months. Imbalances in intestinal flora are common in chronic kidney disease and are linked to complications such as malnutrition and anemia, which affect patients well-being and long-term outcomes. Participants are randomly assigned to two groups one receives a daily oral postbiotics drink called Yien Yuan Honey Fermented Drink for 12 weeks, while the other receives a placebo during the same period. After 12 weeks, the first group ends the trial, and the placebo group then receives the postbiotics for another 12 weeks. This design allows comparison of effects between the groups over time. Throughout the study, researchers will assess changes in quality of life scores, nutritional status, diet, gastrointestinal symptoms, and lab markers from baseline to 12 and 24 weeks. Stool and blood samples will be collected to analyze intestinal flora and toxins. Routine blood tests and other health measures will also be monitored to evaluate the participants responses and safety during the trial, which lasts up to 24 weeks for some participants.

CONDITIONS

Brief Title

Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients

Research Team

Y

Yuqing Chen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here